Baltimore's $11bn opioid lawsuit against manufacturers/distributors can proceed to trial.

Baltimore's $11bn opioid lawsuit against manufacturers/distributors can proceed to trial as city judge denies companies' motions to dismiss. Baltimore alleges companies flooded city with millions of legal opioid prescriptions, downplaying addictiveness and aggressively marketing. Trial set for 16 Sept. Baltimore seeks damages to fund opioid abatement plan involving drug treatment, overdose prevention, and other services.

August 15, 2024
7 Articles

Further Reading